One of the primary motivations of our group members is to commercialize new technologies. As a research partner, you will have special visibility to our successful entrepreneur base.
We are always looking for experienced members on our advisory board. We need experts for due diligence advice.
The meetings are limited to the members. On a case by case basis the executive board may permit guests.
Please check the reference section for institutions which help in providing business plan related advice. As a group, it is not possible for us to provide business plan related advice. However, if you apply and your technology / plan gains screening committee interest, we'll assign someone to work with you to make you ready to present.
Yes, however the business plan should still meet our qualifying criteria. We will like to see your due diligence report in addition to conducting our own.
There are no override or management fees; all work is performed on a pro bono basis. MA2 is a volunteer driven group. We do not charge entrepreneurs to present, nor we compensate the executive board, committee members or advisors.
MA2 members invest as individuals but collaborate on due diligence. If we are leading a deal, one member will take a board seat as a representative.
Our screening process can take anywhere between 4-8 weeks.
Having a MA2 member as a champion for your startup, having management team with previous successful startup experience, well thought out business plan, ensuring IP protection, pre-clinical data on a case-by-case basis increase the chances of investment.
The group meets every two months at a research or life science facility. The committees meet at more frequent intervals. Members are expected to attend atleast half of the yearly meetings. Meetings are usually Tuesdays, from 7:30am to 10:30am and are sponsored.
We do not sign Non-Disclosure Agreement. Please note that the business plans will be accessed by the screening committees and other members within the group. Please do not include any confidential information at this stage. In case your company reaches the due-diligence stage, MA2 will discuss your IP protection on a case-by-case basis.